Evidence map›Paper›PMID 25286960›Full record

ArticleBMC genomics2014

Comparative DNA methylome analysis of endometrial carcinoma reveals complex and distinct deregulation of cancer promoters and enhancers.

Bo Zhang, XiaoYun Xing, Jing Li, Rebecca F Lowdon, Yan Zhou, Nan Lin, Baoxue Zhang, Vasavi Sundaram, Katherine B Chiappinelli, Ian S Hagemann and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Bo Zhang
XiaoYun Xing
Jing Li
Rebecca F Lowdon
Yan Zhou
Nan Lin
Baoxue Zhang
Vasavi Sundaram
Katherine B Chiappinelli
Ian S Hagemann
David G Mutch
Paul J GoodfellowDepartment of Genetics, Center for Genome Sciences and Systems Biology, Washington University School of Medicine, St, Louis MO 63108, USA. Paul.Goodfellow@osumc.edu.
Ting Wang
Northeast Normal University · CNWashington University in St. Louis · USJohns Hopkins University · USSecond Military Medical University · CNThe Ohio State University · US

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Nicholas O. Davidson · 2000 to 2026
$30.8M
MOLECULAR ONCOLOGY TRAINING GRANTT32CA113275 · NCI · WASHINGTON UNIVERSITY · PI Matthew J Walter · 2006 to 2026
$5.7M
RESEARCH EDUCATION PROGRAM ON COMPUTATIONAL AND STATISTICAL TOOL DEVELOPMENT FOR ADDICTION GENETICSR25DA027995 · NIDA · WASHINGTON UNIVERSITY · PI MADDEN, PAMELA ANN, RICE, JOHN P. · 2009 to 2019
$4.3M
DECODING THE IMPACT OF TRANSPOSABLE ELEMENTS ON GENE REGULATIONR01HG007175 · NHGRI · WASHINGTON UNIVERSITY · PI WANG, TING · 2014 to 2021
$2.7M
Training At The Interface of Psychology, Neuroscience, and GeneticsT32GM081739 · NIGMS · WASHINGTON UNIVERSITY · PI BARCH, DEANNA · 2007 to 2016
$2.1M
Tissue and Pathology CoreP50CA134254 · NCI · WASHINGTON UNIVERSITY · PI POLLOCK, PAMELA M, POWELL, MATTHEW A · 2009 to 2011
$1.7M
ADVANCED EPI/GENOME BROWSER WITH ENHANCED VISUALIZATION AND ANALYSIS TOOLSR01HG007354 · NHGRI · WASHINGTON UNIVERSITY · PI WANG, TING · 2013 to 2016
$1.5M
CHARTING THE EPIGENOMIC LANDSCAPE OF HUMAN TRANSPOSABLE ELEMENTSR01ES024992 · NIEHS · WASHINGTON UNIVERSITY · PI WANG, TING · 2014 to 2015
$342k
NCI NIH HHS P30 CA091842NCI NIH HHS P50 CA134254NCI NIH HHS T32 CA113275NHGRI NIH HHS R01 HG007175NHGRI NIH HHS R01 HG007354NIDA NIH HHS R25 DA027995NIDDK NIH HHS P30 DK052574NIEHS NIH HHS R01 ES024992NIGMS NIH HHS T32 GM081739
6 · The paper itself

Abstract

backgroundAberrant DNA methylation is a hallmark of many cancers. Classically there are two types of endometrial cancer, endometrioid adenocarcinoma (EAC), or Type I, and uterine papillary serous carcinoma (UPSC), or Type II. However, the whole genome DNA methylation changes in these two classical types of endometrial cancer is still unknown.

resultsHere we described complete genome-wide DNA methylome maps of EAC, UPSC, and normal endometrium by applying a combined strategy of methylated DNA immunoprecipitation sequencing (MeDIP-seq) and methylation-sensitive restriction enzyme digestion sequencing (MRE-seq). We discovered distinct genome-wide DNA methylation patterns in EAC and UPSC: 27,009 and 15,676 recurrent differentially methylated regions (DMRs) were identified respectively, compared with normal endometrium. Over 80% of DMRs were in intergenic and intronic regions. The majority of these DMRs were not interrogated on the commonly used Infinium 450K array platform. Large-scale demethylation of chromosome X was detected in UPSC, accompanied by decreased XIST expression. Importantly, we discovered that the majority of the DMRs harbored promoter or enhancer functions and are specifically associated with genes related to uterine development and disease. Among these, abnormal methylation of transposable elements (TEs) may provide a novel mechanism to deregulate normal endometrium-specific enhancers derived from specific TEs.

conclusionsDNA methylation changes are an important signature of endometrial cancer and regulate gene expression by affecting not only proximal promoters but also distal enhancers.

Indexed as

Adaptor Proteins, Signal TransducingAldehyde Dehydrogenase 1 FamilyCarcinoma, PapillaryChromosomes, Human, XCpG IslandsDNA (Cytosine-5-)-MethyltransferasesDNA MethylationDNA Transposable ElementsEndometrial NeoplasmsEnhancer Elements, GeneticFemaleHumansKruppel-Like Factor 4Kruppel-Like Transcription FactorsMutL Protein Homolog 1Nuclear ProteinsAdaptor Proteins, Signal TransducingAldehyde Dehydrogenase 1 FamilyALDH1A2 protein, humanDNA (Cytosine-5-)-MethyltransferasesDNA Transposable ElementsKruppel-Like Factor 4Kruppel-Like Transcription FactorsMLH1 protein, humanMutL Protein Homolog 1Nuclear ProteinsRetinal DehydrogenaseRNA, Long NoncodingXIST non-coding RNA

Identifiers

PMID25286960
PMCPMC4198682
OpenAlexW2030403353

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.